Induction of apolipoprotein A-I gene expression by black seed (Nigella sativa) extracts

References

• Ahmad S, Beg ZH. (2013). Elucidation of mechanisms of actions of thymoquinone-enriched methanol and volatile oil extracts from Nigella sativa against cardiovascular risk parameters in experimental hyperlipidemia. Lipids Health Disease 12:86
   PubMed Web of Science ®Google Scholar
• , AIM-HIGH InvestigatorsBoden WE, Probstfield JL, Anderson T, et al. (2011). Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. New Engl J Med 365:2255–67
   PubMed Web of Science ®Google Scholar
• Al-Jenoobi FI, Al-Thukair AA, Abbas FA, et al. (2010). Effect of black seed on dextromethorphan O- and N-demethylation in human liver microsomes and healthy human subjects. Drug Metabol Lett 4:51–5
   Google Scholar
• Atta-ur-Rahman, Malik S, Hasan SS, et al. (1995). Nigellidine, a new indazole alkaloid from the seeds of Nigella sativa. Tetrahedron Lett 36:1993–6
   Web of Science ®Google Scholar
• Burtis M, Bucar F. (2000). Antioxidant activity of Nigella sativa essential oil. Phytother Res 14:323–8
   PubMed Web of Science ®Google Scholar
• Cerda A, Hirata MH, Hirata RD. (2012). Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport. Drug Metabol Drug Interact 27:101–11
   PubMedGoogle Scholar
• Chomczynski P, Sacchi N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 132:6–13
   Google Scholar
• Colin S, Briand O, Touche V, et al. (2013). Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production. Eur Heart J 34:2566–74
   Google Scholar
• Dahri AH, Chandiol AM, Rahoo AA, Memon RA. (2005). Effect of Nigella sativa (kalonji) on serum cholesterol of albino rats. J Ayub Med Coll, Abbottabad 17:72–4
   Google Scholar
• Devchand PR, Keller H, Peters JM, et al. (1996). The PPARalpha-leukotriene B4 pathway to inflammatory control. Nature 384:39–43
   PubMed Web of Science ®Google Scholar
• Fararh KM, Atoji Y, Shimizu Y, Takewaki T. (2002). Insulinotropic properties of Nigella sativa oil in streptozotocin plus nicotinamide diabetic hamster. Res Vet Sci 73:279–82
   PubMed Web of Science ®Google Scholar
• Ghosh RK, Ghosh SM. (2012). Current status of CETP inhibitors in the treatment of hyperlipidemia: An update. Curr Clin Pharm 7:102–10
   PubMedGoogle Scholar
• Gordon T, Castelli WP, Hjotland MC, et al. (1977). High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med 62:707–14
   PubMed Web of Science ®Google Scholar
• Gorman CM, Moffat LF, Howard BH. (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2:1044–51
   PubMed Web of Science ®Google Scholar
• Haas MJ, Horani MH, Wong NC, Mooradian AD. (2004). Induction of the apolipoprotein AI promoter by Sp1 is repressed by saturated fatty acids. Metabolism 53:1342–8
   Google Scholar
• Haas MJ, Mooradian AD. (2010a). Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection. Drugs 70:805–21
   Google Scholar
• Haas MJ, Mooradian AD. (2010b). Regulation of high-density lipoprotein by inflammatory cytokines: Establishing links between immune dysfunction and cardiovascular disease. Diab Metabol Res Rev 26:90–9
   Google Scholar
• Hachem SB, Mooradian AD. (2006). Familial dyslipidaemias: An overview of genetics, pathophysiology and management. Drugs 66:1949–69
   PubMed Web of Science ®Google Scholar
• Herbomel P, Bourachot B, Yaniv M. (1984). Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell 39:653–62
   PubMed Web of Science ®Google Scholar
• Hossain M, Tsujita M, Gonzalez F, Yokoyama S. (2008). Effects of fibrate drugs on expression of ABCA1 and HDL biogenesis in hepatocytes. J Cardiovas Pharm 51:258–66
   PubMed Web of Science ®Google Scholar
• Hostetler HA, Petrescu AD, Kier AB, Schroeder F. (2005). Peroxisome proliferator-activated receptor α interacts with high affinity and is conformationally responsive to endogenous ligands. J Biol Chem 280:18667–82
   PubMed Web of Science ®Google Scholar
• Houghton PJ, Zarka R, de las Heras B, Hoult JR. (1995). Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 61:33–6
   PubMed Web of Science ®Google Scholar
• Meral I, Yener Z, Kahraman T, Mert N. (2001). Effect of Nigella sativa on glucose concentration, lipid peroxidation, anti-oxidant defense system and liver damage in experimentally-induced diabetic rabbits. J Vet Med A: Phys Path Clin Med 48:593–9
   PubMedGoogle Scholar
• Mooradian AD. (2003). Cardiovascular disease in type 2 diabetes mellitus: Current management guidelines. Arch Int Med 163:33–40
   PubMed Web of Science ®Google Scholar
• Mooradian AD, Haas MJ, Wadud K. (2006). Ascorbic acid and alpha-tocopherol down-regulate apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines. Metabolism 55:159–67
   PubMed Web of Science ®Google Scholar
• Mooradian AD, Haas MJ, Wehmeier KR, Wong NC. (2008). Obesity-related changes in high-density lipoprotein metabolism. Obesity (Silver Spring) 16:1152–60
   PubMed Web of Science ®Google Scholar
• Mossman T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 65:55–63
   PubMed Web of Science ®Google Scholar
• Sayed MD. (1980). Traditional medicine in health care. J Ethnopharmacol 2:19–22
   PubMed Web of Science ®Google Scholar
• Smith PK, Krohn RI, Hermanson GT, et al. (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85
   PubMed Web of Science ®Google Scholar
• Worthen DR, Ghosheh O, Crooks PA. (1998). The in vitro anti-tumor activity of some crude and purified components of black seed. Anticancer Res 18:1527–32
   PubMed Web of Science ®Google Scholar
• Xu HE, Lambert MH, Montana VG, et al. (2001). Structural determinations of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc Nat Acad Sci USA 98:13919–24
   PubMed Web of Science ®Google Scholar